loading

LONGEVITY HEALTH HLDGS Stock (XAGE) Forecast

The LONGEVITY HEALTH HLDGS (XAGE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.115, representing a +2.68% increase from the current price of $0.112. The highest analyst price target is $0.2274, and the lowest is $0.00262.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XAGE Price Target
Average 0.1143 (+2.02% Upside)
loading

Is LONGEVITY HEALTH HLDGS (XAGE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 31.79 Neutral
STOCH(9,6) 0.9787 Buy
STOCHRSI(14) 2.3646 Buy
MACD(12,26) -0.0356 Sell
ADX(14) 14.98 Neutral
William %R -99.11 Buy
CCI(14) -44.92 Neutral
Buy: 3 Sell: 1 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.1293
Sell
0.132
Sell
MA20
0.1711
Sell
0.1605
Sell
MA50
0.2242
Sell
0.2128
Sell
MA100
0.2743
Sell
0.2745
Sell
MA200
0.3505
Sell
0.00
Buy
Buy: 1 Sell: 9 Neutral: 0
Summary: Sell
According to our latest analysis, XAGE could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on XAGE, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 31.79 indicates that XAGE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 0.9787 indicates that XAGE is oversold. This indicates that XAGE price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.3646 indicates that XAGE is oversold. This suggests that XAGE price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 14.98 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -44.92 indicates that XAGE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term XAGE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about LONGEVITY HEALTH HLDGS financial reports and earnings history, LONGEVITY HEALTH HLDGS (XAGE) stock could reach $0.5587 by 2030, $1.358 by 2040 and $9.8556 by 2050. See the projected annual prices until 2050 of the LONGEVITY HEALTH HLDGS stock below:

  • LONGEVITY HEALTH HLDGS (XAGE) is expected to reach an average price of $1.0345 in 2035, with a high prediction of $1.1764 and a low estimate of $1.0345. This indicates an $823.67% rise from the last recorded price of $0.112.
  • LONGEVITY HEALTH HLDGS (XAGE) stock is projected to chart a bullish course in 2040, with an average price target of $1.0266, representing an $816.60% surge from its current level. The forecast ranges from a conservative $1.0266 to a sky-high $1.358.
  • Our analysts predict LONGEVITY HEALTH HLDGS (XAGE) to jump 7,482% by 2045, soaring from $8.4951 to an average price of $8.4917, potentially reaching $8.7952. While $8.4951 is the low estimate, the potential upside is significant.
  • LONGEVITY HEALTH HLDGS (XAGE) stock is expected to climb by 2050, reaching an average of $9.552, a $8,429% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.8556 and $9.552, respectively, highlighting the market's uncertainty.

LONGEVITY HEALTH HLDGS Stock (XAGE) Year by Year Forecast

LONGEVITY HEALTH HLDGS Stock (XAGE) Price Forecast for 2026

The predicted value for LONGEVITY HEALTH HLDGS (XAGE) in 2026 is set at an average of $0.2642. Estimates vary from a peak of $0.5258 to a trough of $0.00262, indicating an +135.90% surge from the present price of $0.112.
Month Average Low High Change from today's price
November, 2026 $0.0173 $0.00262 $0.2274 -84.60%
December, 2026 $0.1119 $0.0902 $0.092 -0.12%

LONGEVITY HEALTH HLDGS Stock (XAGE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for LONGEVITY HEALTH HLDGS (XAGE) is $0.0983, with a high forecast of $0.1965 and a low forecast of $0.000032. This indicates an -12.24% decrease from the last price of $0.112.
Month Average Low High Change from today's price
January, 2027 $0.0879 $0.0879 $0.0166 -21.49%
February, 2027 $0.1832 $0.0795 $0.1355 +63.56%
March, 2027 $0.136 $0.1602 $0.1537 +21.40%
April, 2027 $0.0581 $0.1365 $0.1349 -48.17%
May, 2027 $0.0932 $0.0898 $0.0932 -16.77%
June, 2027 $0.0118 $0.0198 $0.1608 -89.45%
July, 2027 $0.0419 $0.00336 $0.1965 -62.57%
August, 2027 $0.00422 $0.00422 $0.0748 -96.23%
September, 2027 $0.00336 $0.00114 $0.0281 -97.00%
October, 2027 $0.0349 $0.00148 $0.1045 -68.84%
November, 2027 $0.0103 $0.00717 $0.0518 -90.81%
December, 2027 $0.000032 $0.000032 $0.0155 -99.97%

LONGEVITY HEALTH HLDGS Stock (XAGE) Price Forecast for 2028

In 2028, LONGEVITY HEALTH HLDGS (XAGE) is projected to reach an average price of $0.3183, with a high projection of $0.6282 and a low estimate of $0.00849. This indicates an +184.22% rise from the last price of $0.112.
Month Average Low High Change from today's price
January, 2028 $0.3922 $0.00849 $0.4021 +250.14%
February, 2028 $0.5906 $0.6052 $0.5954 +427.29%
March, 2028 $0.6807 $0.6493 $0.5268 +507.76%
April, 2028 $0.7013 $0.589 $0.5349 +526.17%
May, 2028 $0.6275 $0.6278 $0.6282 +460.28%
June, 2028 $0.5699 $0.5699 $0.5854 +408.88%
July, 2028 $0.4731 $0.5013 $0.523 +322.39%
August, 2028 $0.3867 $0.3877 $0.4674 +245.24%
September, 2028 $0.33 $0.3268 $0.3436 +194.64%
October, 2028 $0.2854 $0.2854 $0.2731 +154.82%
November, 2028 $0.2377 $0.2377 $0.2506 +112.25%
December, 2028 $0.1879 $0.20 $0.2348 +67.81%

LONGEVITY HEALTH HLDGS Stock (XAGE) Price Forecast for 2029

The 2029 price forecast for LONGEVITY HEALTH HLDGS Stock (XAGE) is $0.6381 on average, with a high prediction of $1.1811 and a low estimate of $0.095. This represents an +469.70% increase from the previous price of $0.112.
Month Average Low High Change from today's price
January, 2029 $0.1556 $0.1324 $0.1366 +38.88%
February, 2029 $0.1343 $0.1219 $0.1385 +19.89%
March, 2029 $1.144 $0.095 $0.984 +921.43%
April, 2029 $1.2056 $1.1786 $1.0625 +976.41%
May, 2029 $1.2156 $1.2109 $1.1811 +985.35%
June, 2029 $1.124 $1.124 $1.0702 +903.55%
July, 2029 $1.0523 $1.0986 $1.1208 +839.54%
August, 2029 $1.0197 $1.0457 $1.0882 +810.49%
September, 2029 $0.8742 $0.9695 $0.9848 +680.50%
October, 2029 $0.7473 $0.8551 $0.8416 +567.20%
November, 2029 $0.6756 $0.6836 $0.6755 +503.26%
December, 2029 $0.5542 $0.6196 $0.6234 +394.85%

LONGEVITY HEALTH HLDGS Stock (XAGE) Price Forecast for 2030

LONGEVITY HEALTH HLDGS Stock (XAGE) is expected to reach an average price of $0.9827 in 2030, with a high forecast of $1.7668 and a low forecast of $0.1985. This signifies an +777.38% surge from the last price of $0.112.
Month Average Low High Change from today's price
January, 2030 $0.5073 $0.5073 $0.5587 +352.98%
February, 2030 $0.4405 $0.4548 $0.482 +293.33%
March, 2030 $0.3413 $0.3413 $0.3251 +204.74%
April, 2030 $0.2813 $0.2814 $0.3159 +151.18%
May, 2030 $0.2239 $0.2239 $0.2592 +99.91%
June, 2030 $1.6143 $0.1985 $1.6412 +1,341%
July, 2030 $1.7281 $1.8071 $1.7668 +1,443%
August, 2030 $1.7506 $1.7361 $1.6136 +1,463%
September, 2030 $1.7035 $1.6082 $1.5879 +1,421%
October, 2030 $1.5451 $1.5454 $1.6135 +1,280%
November, 2030 $1.4199 $1.4199 $1.4861 +1,168%
December, 2030 $1.2378 $1.2378 $1.356 +1,005%
Cap:     |  Volume (24h):